Pseudomonas aeruginosa serotypes in nosocomial pneumonia: prevalence and clinical outcomesQin Lü, Jean‐Jacques Rouby, Charles‐Édouard Luyt et al.|Critical Care|2014Cited by 90
CAL02, a novel antitoxin liposomal agent, in severe pneumococcal pneumonia: a first-in-human, double-blind, placebo-controlled, randomised trialPierre‐François Laterre, Bruno François, Thierry Boulain et al.|The Lancet Infectious Diseases|2019Cited by 59